Live Breaking News & Updates on Reviva Pharmaceuticals Holdings

Stay updated with breaking news from Reviva pharmaceuticals holdings. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FY2023 EPS Estimates for Reviva Pharmaceuticals Holdings, Inc. Reduced by Analyst (NASDAQ:RVPH)

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Free Report) – Equities researchers at Zacks Small Cap lowered their FY2023 EPS estimates for Reviva Pharmaceuticals in a research note issued to investors on Monday, November 20th. Zacks Small Cap analyst J. Vandermosten now forecasts that the company will post earnings per share of ($1.43) for the year, […] ....

Roth Mkm , Reviva Pharmaceuticals Company Profile , Reviva Pharmaceuticals Trading , Reviva Pharmaceuticals , Wells Fargo Company , Institutional Trading Of Reviva Pharmaceuticals , Tower Research Capital , Reviva Pharmaceuticals Holdings Inc , Colony Group , Capital Partners , News Ratings For Reviva Pharmaceuticals Daily , Reviva Pharmaceuticals Holdings , Free Report , Zacks Small Cap , Small Cap , Reviva Pharmaceutical , Research Capital , Get Free Report , Pharmaceuticals Holdings , Reviva Pharmaceuticals Daily , Nasdaq Rvph , Earnings Estimates ,

Reviva Pharmaceuticals (RVPH) Announces $30 Million Registered Direct Offering of Common Stock, Warrants

Reviva Pharmaceuticals (RVPH) Announces $30 Million Registered Direct Offering of Common Stock, Warrants
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Company Board Of Directors , Reviva Pharmaceuticals Holdings Inc , Hc Wainwright Co , Reviva Pharmaceuticals Holdings ,

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Misses Q3 EPS by 8c

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Misses Q3 EPS by 8c
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Reviva Pharmaceuticals Holdings Inc , Reviva Pharmaceuticals Holdings ,

Reviva's brilaroxazine hits phase III schizophrenia endpoint, propels stock upward

The pivotal phase III study of brilaroxazine from Reviva Pharmaceuticals Holdings Inc. for adults with schizophrenia hit its primary endpoint and two key secondary endpoints, following positive phase II data in 2021. The serotonin-dopamine signaling modulator, the company’s lead candidate, is a once-daily treatment. ....

Reviva Pharmaceuticals Holdings Inc , Reviva Pharmaceuticals Holdings , Minerva Neurosciences Inc , Phase Iii , Karuna Therapeutics Inc , Reviva Pharmaceuticals Holdings Inc , Cerevel Therapeutics Holdings Inc ,